Related Experiment Video

Updated: Aug 13, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Structure-activity relationships for triphenylethylene antiestrogens on hepatic phase-I and phase-II enzyme

E F Nuwaysir1, Y P Dragan, R McCague

  • 1Environmental Toxicology Center, University of Wisconsin, Madison, USA.

Biochemical Pharmacology
|September 23, 1998
PubMed

Insights

Tamoxifen

Area of Science:

  • Pharmacology and Toxicology
  • Enzyme Kinetics
  • Drug Metabolism

Background:

  • Tamoxifen is a widely used drug with known effects on liver enzymes.
  • Understanding the precise mechanisms of tamoxifen's action is crucial for optimizing its therapeutic use and predicting potential drug interactions.

Purpose of the Study:

  • To elucidate the distinct mechanisms by which tamoxifen and its analogs induce rat hepatic CYPIIB2 and suppress glutathione S-transferase alpha 1 (GSTA1).
  • To investigate the structure-activity relationships governing these two distinct biological effects.

Main Methods:

  • Synthesis and testing of a series of tamoxifen analogs, including fixed-ring tamoxifen, ethylated fixed-ring tamoxifen, pyrrolidino-tamoxifen, 4-iodotamoxifen, idoxifene, and toremifene.
  • Assessing the ability of these compounds to induce CYPIIB2 and suppress GSTA1 in rat liver models.
  • Comparing the observed structure-activity relationships with known activities such as estrogen receptor binding and calmodulin antagonism.

Main Results:

  • The aminoethoxy side chain is critical for GSTA1 suppression, with 4-iodination potentially enhancing this activity.
  • CYPIIB2 induction is not dependent on the aminoethoxy side chain, as demonstrated by the differential activity of various analogs.
  • Differential activities of analogs in CYPIIB2 induction and GSTA1 suppression confirm distinct mechanistic pathways for these effects.

Conclusions:

  • Tamoxifen-induced CYPIIB2 induction and GSTA1 suppression in rats operate via separate and distinct mechanistic pathways.
  • The mechanisms underlying CYPIIB2 induction and GSTA1 suppression by triphenylethylenes are unrelated to estrogen receptor binding, calmodulin antagonism, antiuterotrophic activity, or MCF-7 cell growth antagonism.

More Related Videos

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

Related Concept Videos

Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...